Intelligent Bio Solutions Inc. Common Stock
$1.95
-$0.05 (-2.50%)
$1.90Day Range$2.00
Key Statistics
Market Cap
$6.47M
Shares Outstanding
3.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 23, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$2.00
Day High
$2.00
Day Low
$1.90
Volume
35.4K
VWAP
$1.93
Prev Close
$2.00
Transactions
--
Acc. Volume
--
About Intelligent Bio Solutions Inc. Common Stock
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384160 employees135 W 41ST ST,, NEW YORK, NY, 10036646-790-5756IPO Dec 23, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001725430
- Composite FIGI
- BBG004TP0VX9
- Share Class FIGI
- BBG004TP0VY8
- Ticker Root
- INBS
- SIC Code
- 3841
About Intelligent Bio Solutions Inc. Common Stock (INBS) Stock
Intelligent Bio Solutions Inc. Common Stock (INBS) closed the 2026-09-18 session at $1.95, down 2.50% versus the previous close (-0.05). The stock opened at $2.00 and traded between $1.90 and $2.00 during that session. Session trading volume was 35K shares. The volume-weighted average price (VWAP) is $1.93.
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
Intelligent Bio Solutions Inc. Common Stock has a market capitalization of $6.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. INBS is listed on the XNAS exchange. The company employs approximately 60 people. Intelligent Bio Solutions Inc. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2020-12-23.
On this page you can find market INBS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.